These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 13521871
1. Studies on the in vitro and in vivo effect of cycloserine and isoniazid on tubercle bacilli. TRUANT JP. Antibiot Annu; ; 5():630-4. PubMed ID: 13521871 [No Abstract] [Full Text] [Related]
2. The effect of cycloserine on growing and resting tubercle bacilli. HUDGINS PC, PATNODE RA, CUMMINGS MM. Am Rev Tuberc; 1955 Nov; 72(5):685-6. PubMed ID: 13259089 [No Abstract] [Full Text] [Related]
3. Studies on action mechanisms of antituberculous drugs. III. Fundamental studies of cycloserine, especially its effects upon dehydrogenase and catalase of tubercle bacilli. TAKASHINA J. Sci Rep Res Inst Tohoku Univ Med; 1957 Mar; 7(3):303-8. PubMed ID: 13432823 [No Abstract] [Full Text] [Related]
4. A new antibiotic against tubercle bacilli (homomycin). KANAI K, SATO N, TACHIBANA T, YANAGISAWA K. Jpn J Med Sci Biol; 1956 Jun; 9(3):129-32. PubMed ID: 13376200 [No Abstract] [Full Text] [Related]
19. Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro. COHN ML, ODA U, KOVITZ C, MIDDLEBROOK G. Am Rev Tuberc; 1954 Sep 30; 70(3):465-75. PubMed ID: 13189061 [No Abstract] [Full Text] [Related]
20. The influence of chemoantibiotic treatment on tubercle bacilli (culture properties and guinea pig pathogenicity). HEDVALL E. Dis Chest; 1955 Oct 30; 28(4):391-405. PubMed ID: 13261861 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]